Manufacturers Eye Challenges Of Broadening Cell And Gene Therapy Access

With more advanced therapies gaining approval, companies at ARM’s Cell and Gene Meeting on the Mesa considered hurdles to making their products more broadly available and developing them for larger indications.

Back to news